Description: ChromaDex Corporation, a natural products company, through its subsidiaries, discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies. The company supplies bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. It also provides a range of contract services, including routine contract analysis for the production of dietary supplements, cosmetics, foods, and other natural products, as well as elaborate contract research for clients in these industries; and consulting services in the areas of regulatory support, new ingredient or product development, risk management, and litigation support, as well as product regulatory approval and scientific advisory services. The company's products and services in development include Nicotinamide riboside, a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene and caffeine co-crystal that are ingredients for the formulation of energy products; and Anthocyanins for application in dietary supplement, sports nutrition, food and beverage, and skin care products. In addition, it is developing quality verification seal program, phytochemical libraries, plant extracts libraries, and databases for cross-referencing phytochemicals. The company markets and sells its products directly in the United States and Canada; and through distributors in Europe, South America, China, Korea, India, Japan, Australia, New Zealand, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation is headquartered in Irvine, California.
Home Page: www.chromadex.com
CDXC Technical Analysis
10900 Wilshire Boulevard
Los Angeles,
CA
90024
United States
Phone:
310 388 6706
Officers
Name | Title |
---|---|
Mr. Frank Louis Jaksch Jr. | Co-Founder & Chairman |
Mr. Robert N. Fried | CEO & Director |
Ms. Brianna Gerber | Sr. VP of Fin., VP of Investor Relations & Interim CFO |
Dr. Andrew Shao Ph.D. | Sr. VP of Global Regulatory & Scientific Affairs |
Heather Van Blarcom | Sr. VP of Legal & Corp. Sec. |
Alex Worsham | VP of Global Marketing & Communications |
Mr. Fadi Karam | Chief Marketing Officer |
David Kroes | Sr. VP of People Matters |
Ms. Chu Yan | Managing Director of Asia Pacific |
Tom Shumaker | Managing Director of LifeSci Advisors |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 5.4905 |
Price-to-Sales TTM: | 1.7315 |
IPO Date: | 2008-07-15 |
Fiscal Year End: | December |
Full Time Employees: | 115 |